This module introduces the mouse T lymphocyte proliferation assay.
Author: J.E. Colligan et al, Translator: Xuitao Cao et al, This experiment is from the "Compendium of Immunology Laboratory Guide".
Operation method
T lymphocyte proliferation assay Move Basic scenario 1 Activation of un-sensitized T lymphocytes Material This approach is used when the anti-CD3/TCR complex antibody does not bind effectively to the Fc receptor on mouse helper cells or when its soluble form does not effectively activate T cells. It should be noted that in cases where a particular antibody (e.g., anti-G 7, Thy-I monoclonal antibody) has difficulty in inducing a proliferative response in T cells, Basic Protocol 1 is recommended. P B S (room temperature and 4°C) Prepare lm g/m l of purified anti-CD3 or anti-TCR monoclonal antibody (non-specific activation of T cells) or lm g/m l of purified anti-V news or anti-TCR-yS monoclonal antibody (specific activation of T cells, Table 1) with PBS. 1. In a 4 ml polystyrene conical-bottom centrifuge tube, use sterile room-temperature PBS (protein-free) to mix lmg/ml of sterile monoclonal antibody storage solution (Table 2.11.1) with 4 concentrations of the working solution according to the experimental needs: e.g. lOOug/ml, 10ug/ml, 1ug/ml, O.lug/ml, and make it up before use. 2 . Add 30 ul of each concentration of Antibody Working Solution (up to 2-3 ug per well; optimal concentration is usually 10ug/ml) to a 96-well round bottom plate (one row for each monoclonal antibody) and use 30/xl of PBS as a control well. 3 . Cover the plate and tap the side of the plate to ensure that the bottom of the wells are completely covered with liquid. Incubate at 37°C for 90 min or 4°C overnight. Proceed with the next step while incubating. 4 . Prepare a reaction cell suspension (highly purified, but the auxiliary cells do not affect the results of the experiment) as in Steps 1 to 3 of Basic Protocol 1. 5 . Add 200ul of pre-cooled PBS to each well and wash the wells of the above antibody-coated culture plate, invert the plate in the ultra-clean bench and tap it on absorbent paper to remove the residual liquid, and re-wash the plate 2 or 3 times to ensure that the excess antibody is removed. 6 . Add 2 X 105 cells/(0.2 ml-well) of the prepared cell suspension to the washed plate (to be determined empirically; hybridoma supernatant should not be used). If the cells are not ready at the moment, add 100M PBS and store at 4°C overnight (PBS should be removed before adding cells). 7 . Follow steps 7 to 9 in the basic protocol1 , and add 3H TdR after 2 to 3d of incubation (perform kinetic experiments to determine the optimal time). The main purpose of this method is to exclude helper T cells. Methods for purification and enrichment of antigen-presenting cells are described in the relevant sections; the methods described in Module 2.3 do not exclude T cells and are therefore not recommended. Splenocytes from unimmunized mice genetically homologous to the reactive T cells H B S S Low-toxicity rabbit supplement (Cedarlane), diluted in ice-cold sterile deionized water Anti-Thy-l.2 monoclonal antibody (H ○ -13-4, ATCCNO . TIB9 9 ) or anti-Thy-l.l monoclonal antibody (H ○ -22-l , A T C C n o . TIB1 0 0 ; or other anti-Thy-I monoclonal antibodies See C P I M Table 3.4.1 and Ascitic fluid preparation. Note: Most investigators preferentially use mitomycin C to inactivate cells when antigenic differences in the genetic code need to be examined or when an irradiated source is not available. Mitomycin C Inactivated Cells Cells maintain antigen-presenting function; after 1100 ~ 2000 rad radiation, antigen-presenting ability decreased dramatically; > 20,000 m d inactivation of B cells lost APC function. On the other hand, macrophages and dendritic cells still maintain the function of antigen presentation after 3000 rad irradiation. To ensure that B cells do not participate in the response, some researchers prefer 2000 rad. However, when detecting antigens that stimulate the cellular MLS locus, < 1000 m d of radiation should be used because B cells are more efficient at presenting MLS antigens. Alternatively, the Mls response can be detected after mitomycin C treatment, which maintains the antigen-presenting function of the treated B cells. When transformed cell lines are used as antigen presenting or helper cells, high intensity irradiation is used to block their proliferation. The appropriate radiation intensity for each cell line needs to be determined on a pre-test basis, but should be at least 5000 rad; some transformed cell lines may require up to 10,000 to 20,OOO rad, or some may be more sensitive to mitomycin C. The radiation intensity for each cell line should be determined on a pre-test basis, but should be at least 5000 rad; some transformed cell lines may require up to 10,000 to 20,OOO rad or some may be more sensitive to mitomycin C. (It reaches its peak on day 4 or 5). C D 4+C D 25+ T cells and analyze their suppressive function For more product details, please visit Aladdin Scientific website.
![自上清或腹水,至少使用四种稀释度)、毒 素 (确认使用的小鼠表达能够结合毒素的 1^^[(: 11分子)或凝集素:用 ?: 83将111^/1111储存液进行四种稀释度,如100] ^/1111、 30Mg/ml、 10Mg/m l 和 3Mg/m l ,由于蛋白质会结合到塑料上,因此稀释后应马上使 用 。对于药物,用 P B S 配制成合适浓度即可,如 P M A , lOOng/m l ; A 23187, Iyg/ ml (或 4/xg/m l 离子霉素)。 5 . 加 入 2〇 4 各种不同稀释度的活化剂(单抗、肠毒素或凝集素)至 96 孔平底或圆底板 中,设 置 3 个 复 孔 ,如每种激活剂用一行。对 照 孔 加 入 20M1 P B S 。由 于 P M A 和 A 23187的剂量-反应曲线很窄,所以只需用一个浓度,即 加 入 第 4 步中给出浓度的 2〇 W P M A 或钙离子载体。 6 . 在含有活化剂的9 6 孔板中加入2 X I O 5 个细胞/0. 2m l 。 7 . 将 9 6 孔 板 置 37°C , 5 % C 0 2 的培养箱中培养2〜4d (依经验决定培养时间)。 8 . 每孔加入3H T d R ,然后 置 C O 2 培养箱中继续培养18〜24h ,用半自动样品收集器收 集样品,并 用 P 液闪仪检测cpm值 。 9a. Acpm值 (大部分文献推荐):用 实 验 组 (刺激组)三 个 复 孔 的 cpm 平均值减去对 照 组 (未加刺激剂组)三个复孔的平均值,得出实验组的Acpm值 。 9b. 实验组和对照组cpm 的比值:实 验 组 cpm 的平均值除以相应对照组的cpm 平均值 (结果表示为刺激指数或SI)。 注 :本底的微小变化将引起SI值的很大变化,在分析结果时应特别注意。](http://img.dxycdn.com/trademd/upload/userfiles/image/2016/07/A1469503092907v5r864jqyapng_small.jpg)
Option 1 Activation of unsensitized T cells with antibodies
2.11.1)
Adjuvant regimen 1 Elimination of T lymphocytes from antigen-presenting or stimulating cell suspensions



![0 0 4 + 002 5 — 和〇 04+ 0 0 2 5 + 丁 细 胞 (单元2.2) n/ R P M I -I O 完全培养基 辅助细胞: T 细胞剔除的经辐射灭活的脾细胞悬液(单 元 2. 2 , 辅 助 方 案 1) 纯化的抗C D 3 抗 体 (B D PHarmingen) 小鼠或人 IL-2 (PeproTech 或 Roche) 纯化的抗C D 2 8 抗 体 (BDPHaraiingen) 3H T d R 带 盖 9 6 孔平底培养板 37°C , 5 % C 0 2 的培养箱 半自动样品收集器 P 液闪仪 1 . 按 单 元 2. 2 所 述 ,用 R P M I -I O 完 全 培 养 基 分 别 配 制 C D 4 + C D 25—和 C D 4 + C D 25+ T 细胞悬液,计 数 并 调 整 C D 4 + C D 25+和 C D 4 + C D 25+T 细胞浓度分别为IXlO6 个细 胞/ml0 2 . 按辅助方案1 或 单 元 2. 2 所述,用 R P M I -I O 完全培养基准备辅助细胞,计数并调整 细胞浓度为IXlO6个细胞/ml。 3•用R P M I -10完 全 培 养 基 配 制 以 下 抗 体 :抗 C D 3 , l| ug/m l ; IL-2, 200 U /m l ; 抗 C D 28? 2jLtg/ml〇 4 . 每 孔加C D 4+C D 25— T 细 胞 50]ul至 9 6 孔平底板中,共 9 孔 。或 每 孔 加 C D 4 + C D 25+ T 细 胞 50M1,共 9 孔 。 5 . 每孔分别加50m 1辅助细胞和50]ul浓 度 为 lfxg/m l 抗 C D 3 抗体。 6 . 在 其 中 3 孔 C D 25— 和 3 孔 C D 25+细胞中,分 别 加 50/^1浓 度 为 200 U /m l 的 IL-2。 7 . 在 另 外 3 孔 C D 25— 和 3 孔 C D 25+细胞中,分 别 加 50M1抗 C D 2 8 , 每组的剩余3 孔加 5〇 W 的 R P M I -10完全培养基。 8 . 在 9 6 孔 板 中 每 孔 加 入 50M1 C D 4 + C D 25+丁 细 胞 ,做 3 或 4 个 两 倍 系 列 稀 释 C D 4+ C D 25+T 细胞,包括仅含50M1完全培养基的对照孔。每个稀释度设3 个复孔。 9 . 在 步 骤 8 的各孔中每孔加50pd C D 4+C D 25— 细胞、 50M1辅助细胞和50jul浓 度 为 I iUg/ m l 的 抗 C D 3。 10. 将培养板置37°C , 5 % 〜7 % C 〇 2 的培养箱中培养3d (约 66h)。 11•第3 天 ,每孔加3H T d R ,继续培养6〜8h ,用样品收集器收集细胞,并 用 p 液闪仪 测 量 cpm值](http://img.dxycdn.com/trademd/upload/userfiles/image/2016/07/B1469503266741bmtwmfjqvepng_small.jpg)
Option 3 C D 4+C D 25+ A two-step assay of T cell suppressive function: short-term activation and expansion 
